[Comment] Use of data to drive pneumococcal conjugate vaccine policy

In The Lancet Infectious Diseases, Shamez Ladhani and colleagues1 describe changes in invasive pneumococcal disease in the UK over a 17-year period, during which two pneumococcal conjugate vaccines (PCVs) were introduced for infants: the seven-valent vaccine (PCV7) in 2006, and the 13-valent vaccine (PCV13) in 2010.1 The authors estimate that 38  366 invasive pneumococcal disease cases were prevented in England and Wales during the decade of PCV use. Although disease incidence declined by the largest percentage in the vaccine target age group (from 49·00 cases per 100 000 population in 2000–06 to 13·90 per 100 000 in 2016/17), mos t cases were prevented among adults who were not eligible to receive the vaccine.

Source: The Lancet Infectious Diseases - January 25, 2018 Category: Infectious Diseases Authors: Tamara Pilishvili, Cynthia G Whitney Tags: Comment Source Type: research